KSPI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Joint Stock Company Kaspi.kz and Encourages Investors to Contact the Firm!
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Joint Stock Company Kaspi.kz (“Kaspi” or “the Company”) (NASDAQ: KSPI). Investors who purchased Kaspi securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/KSPI.
Investigation Details
On September 19, 2024, Culper Research published a report alleging, among other things, that Kaspi “systematically misled U.S. investors and regulators in its repeated claims–especially ahead of the Company's January 2024 NASDAQ listing–that the Company has zero exposure to Russia”, when in fact “Russia has contributed materially to Kaspi’s reported growth.” Following publication of the Culper Research report, Kaspi’s American Depositary Receipt (“ADR”) price fell $19.20 per ADR, or 16.13%, to close at $99.81 per ADR on September 19, 2024.
What's Next?
If you are aware of any facts relating to this investigation or purchased Kaspi securities, you can assist this investigation by visiting the firm’s site: bgandg.com/KSPI. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
Morningstar’s Guide to Investing in Stocks
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst